Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kotaro Shide

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Anticancer Research|July 3, 2017
Loss of Tyrosine Kinase 2 Does Not Affect the Severity of <i>Jak2</i>V617F-induced Murine Myeloproliferative NeoplasmTakumi Yamaji, Kotaro Shide, Takuro Kameda, et al.
European Journal of Haematology|June 25, 2009
The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in JapanTomonori Hidaka, Kotaro Shide, Haruko Shimoda, et al.
Leukemia|May 31, 2020
Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis miceYoshinori Ozono, Kotaro Shide, Takuro Kameda, et al.
International Journal of Hematology|March 8, 2024
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in JapanKensuke Usuki, Takuro Kameda, Noriaki Kawano, et al.
Journal of Clinical Medicine|January 5, 2021
Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, JapanKeiichi Akizuki, Hitoshi Matsuoka, Takanori Toyama, et al.
Blood|March 29, 2020
Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in miceKotaro Shide, Takuro Kameda, Ayako Kamiunten, et al.
European Journal of Haematology|February 3, 2017
Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practiceMasaaki Sekine, Yoko Kubuki, Takuro Kameda, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|January 15, 2016
TET2 Mutation in Adult T-Cell Leukemia/LymphomaKazuya Shimoda, Kotaro Shide, Takuro Kameda, et al.
Genomics Data|October 21, 2015
Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasmsTakuro Kameda, Kotaro Shide, Takumi Yamaji, et al.
Viruses|April 23, 2022
Prognosis of Indolent Adult T-Cell Leukemia/LymphomaTakuro Kameda, Kotaro Shide, Yuki Tahira, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Anticancer Research|July 3, 2017
Loss of Tyrosine Kinase 2 Does Not Affect the Severity of <i>Jak2</i>V617F-induced Murine Myeloproliferative NeoplasmTakumi Yamaji, Kotaro Shide, Takuro Kameda, et al.
European Journal of Haematology|June 25, 2009
The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in JapanTomonori Hidaka, Kotaro Shide, Haruko Shimoda, et al.
Leukemia|May 31, 2020
Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis miceYoshinori Ozono, Kotaro Shide, Takuro Kameda, et al.
International Journal of Hematology|March 8, 2024
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in JapanKensuke Usuki, Takuro Kameda, Noriaki Kawano, et al.
Journal of Clinical Medicine|January 5, 2021
Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, JapanKeiichi Akizuki, Hitoshi Matsuoka, Takanori Toyama, et al.
Blood|March 29, 2020
Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in miceKotaro Shide, Takuro Kameda, Ayako Kamiunten, et al.
European Journal of Haematology|February 3, 2017
Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practiceMasaaki Sekine, Yoko Kubuki, Takuro Kameda, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|January 15, 2016
TET2 Mutation in Adult T-Cell Leukemia/LymphomaKazuya Shimoda, Kotaro Shide, Takuro Kameda, et al.
Genomics Data|October 21, 2015
Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasmsTakuro Kameda, Kotaro Shide, Takumi Yamaji, et al.
Viruses|April 23, 2022
Prognosis of Indolent Adult T-Cell Leukemia/LymphomaTakuro Kameda, Kotaro Shide, Yuki Tahira, et al.
Pageof 7